“Pregnenolone is considered the inactive precursor of all steroid hormones, and its potential functional effects have been largely uninvestigated.
The administration of the main active principle of Cannabis sativa (marijuana), Δ(9)-tetrahydrocannabinol (THC), substantially increases the synthesis of pregnenolone in the brain via activation of the type-1 cannabinoid (CB1) receptor.
Pregnenolone then, acting as a signaling-specific inhibitor of the CB1 receptor, reduces several effects of THC.
This negative feedback mediated by pregnenolone reveals a previously unknown paracrine/autocrine loop protecting the brain from CB1 receptor overactivation that could open an unforeseen approach for the treatment of cannabis intoxication and addiction.
These data indicate that THC increases pregnenolone through activation of the CB1 receptor…
In conclusion, this new understanding of the role of pregnenolone has the potential to generate new therapies for cannabis dependence.”